Qiming Venture Partners USA raises $260m for third fund

The fund will invest in early-stage therapeutics and healthcare tech companies in the U.S. and the EU.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this